Old Web
English
Sign In
Acemap
>
authorDetail
>
Nan Wang
Nan Wang
Amgen
Evolocumab
Endocrinology
Type 2 diabetes
Internal medicine
Medicine
3
Papers
25
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Effects of evolocumab therapy and low LDL‐C levels on vitamin E and steroid hormones in Chinese and global patients with type 2 diabetes
2020
Dirk J. Blom
Jiyan Chen
Zuyi Yuan
João Lindolfo C. Borges
Maria Laura Monsalvo
Nan Wang
A. Hamer
Junbo Ge
Show All
Source
Cite
Save
Citations (2)
Randomised study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Primary results of the BERSON clinical trial
2019
Diabetes, Obesity and Metabolism
Alberto J. Lorenzatti
Freddy G. Eliaschewitz
Yundai Chen
Juming Lu
Alexis Baass
Maria Laura Monsalvo
Nan Wang
A. Hamer
Junbo Ge
Show All
Source
Cite
Save
Citations (15)
Randomized study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Pre‐specified analysis of the Chinese population from the BERSON clinical trial
2019
Diabetes, Obesity and Metabolism
Yundai Chen
Zuyi Yuan
Juming Lu
Freddy G. Eliaschewitz
Alberto J. Lorenzatti
Maria Laura Monsalvo
Nan Wang
A. Hamer
Junbo Ge
Show All
Source
Cite
Save
Citations (8)
1